Literature DB >> 1630785

Extramacular disciform lesions simulating uveal tumors.

D S Bardenstein1, D H Char, A R Irvine, R D Stone.   

Abstract

PURPOSE: The purpose of this study is to identify clinical, ultrasonographic, and fluorescein angiographic features of extramacular disciform lesions that allow differentiation from uveal tumors.
METHODS: This was a retrospective study of 19 patients referred to our ocular oncology unit with a possible malignancy who had a diagnosis of an extramacular disciform lesion made after complete evaluation.
RESULTS: The level of accuracy for each diagnostic technique alone was as follows: clinical (79%), ultrasonography (83%), and angiography (83%). Fluorescein angiography had limited utility because of severe media opacities in seven cases. No tumor developed an intraocular malignancy during the follow-up period.
CONCLUSION: A combination of the above, noninvasive techniques can be used to correctly diagnose extramacular disciform lesions.

Entities:  

Mesh:

Year:  1992        PMID: 1630785     DOI: 10.1016/s0161-6420(92)31870-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Misleading aspiration biopsy in combined intraocular pathology.

Authors:  W Sekundo; W R Lee; H M Hammer
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

2.  Vasoproliferative tumours of the retina.

Authors:  H Heimann; N Bornfeld; O Vij; S E Coupland; N E Bechrakis; U Kellner; M H Foerster
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

3.  Updated Systematic Review and Clinical Spectrum of Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Abdulrahman H Badawi; Valmore A Semidey; Moustafa Magliyah; Hassan Al-Dhibi
Journal:  Middle East Afr J Ophthalmol       Date:  2020-04-29

4.  Variable Presentations of Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Wael A Alsakran; Abdulaziz A Alshamrani; Yahya A Alzahrani
Journal:  Middle East Afr J Ophthalmol       Date:  2020-01-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.